Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP972238priorityCriticalpatent/ECSP972238A/en
Publication of ECSP972238ApublicationCriticalpatent/ECSP972238A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Hydrogenated Pyridines
(AREA)
Abstract
El invento se refiere a compuestos de fórmula I (gráfico), en la que: R1 y R3 son independientemente hidrógeno, CH3, -CO-(alquilo C1-C6), o -COAr, en el que Ar es fenilo opcionalmente sustituído; R2 es seleccionada entre el grupo formado por pirrolidinilo, hexametilenimino y pieridinilo; o una de sus sales o solvatos farmacéuticamente aceptables, en una forma amorfa.The invention relates to compounds of formula I (graph), wherein: R1 and R3 are independently hydrogen, CH3, -CO- (C1-C6 alkyl), or -COAr, where Ar is optionally substituted phenyl; R2 is selected from the group consisting of pyrrolidinyl, hexamethyleneimino and pieridinyl; or one of its pharmaceutically acceptable salts or solvates, in an amorphous form.
ECSP9722381997-08-261997-08-26
AMORPHOUS BENZOTIOFENS, PROCEDURES FOR ITS PREPARATION AND PROCEDURE FOR ITS USE
ECSP972238A
(en)
PROTEASE INHIBITORS, PROCEDURE FOR THE PREPARATION, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM AND THE USE OF THE SAME IN THE MANUFACTURE OF A MEDICINAL PRODUCT